Active, not recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
NCT06031441
- Conditions
- Locally Advanced Solid Tumors, Metastatic Solid Tumors, Recurrent Solid Tumors
- Locations
-
- University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Icahn School of Medicine at Mount Sinai (ISMMS) New York, United States
- The Ohio State University Columbus, Ohio, United States